ArticleNature reviews. Urology2016
Kidney cancer: No advantage of adjuvant sunitinib or sorafenib.
Louise StonePubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNature reviews. Urology2016
Louise StonePubMed ↗Publisher ↗
No numbers read from the abstract.